Advisors Capital Management LLC Lowers Holdings in HCA Healthcare, Inc. $HCA

by · The Cerbat Gem

Advisors Capital Management LLC cut its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 3.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,844 shares of the company’s stock after selling 153 shares during the quarter. Advisors Capital Management LLC’s holdings in HCA Healthcare were worth $1,329,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of HCA. Brighton Jones LLC purchased a new stake in HCA Healthcare in the 4th quarter worth approximately $1,021,000. NorthRock Partners LLC lifted its stake in HCA Healthcare by 205.6% in the 4th quarter. NorthRock Partners LLC now owns 2,002 shares of the company’s stock worth $601,000 after purchasing an additional 1,347 shares in the last quarter. Man Group plc raised its position in shares of HCA Healthcare by 11.9% during the 4th quarter. Man Group plc now owns 84,156 shares of the company’s stock valued at $25,259,000 after buying an additional 8,972 shares in the last quarter. ProShare Advisors LLC raised its position in shares of HCA Healthcare by 9.5% during the 4th quarter. ProShare Advisors LLC now owns 29,767 shares of the company’s stock valued at $8,935,000 after buying an additional 2,583 shares in the last quarter. Finally, Raiffeisen Bank International AG purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,185,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on HCA shares. Royal Bank Of Canada lowered their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research report on Monday, July 28th. Robert W. Baird raised their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Stephens raised shares of HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Finally, Morgan Stanley reduced their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a report on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $403.17.

Check Out Our Latest Report on HCA

HCA Healthcare Price Performance

HCA stock opened at $405.54 on Friday. The firm has a market cap of $94.89 billion, a P/E ratio of 17.05, a P/E/G ratio of 1.27 and a beta of 1.41. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $420.98. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The firm’s fifty day moving average is $382.88 and its 200 day moving average is $362.77.

HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading